Eric Hollander, M.D.

Psychiatry and Behavioral Sciences

Phone718-839-7516
Emaileholland@montefiore.org
Websitehttp://www.einstein.yu.edu/faculty/11986/eric-hollander/

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research activity per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where Eric Hollander is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

7 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

10 Finished

Phase 2 Study: Intranasal Oxytocin vs. Placebo for the Treatment of Hyperphagia in Prader-Willi Syndrome [IND 121109 acknowledged 8/27/14]
Hollander, E.
National Institutes of Health
9/1/17 → 8/31/20
Project: Research project
FLUOXETINE IN PEDIATRIC BODY DYSMORPHIC DISORDER
Hollander, E. & Hollander, E.
4/1/05 → 3/31/09
Project: Research project
Training in Psychopharmacology and Outcomes Research
Hollander, E., Rieder, R., Rose, S. A. & Rose, S. A.
National Institute of Mental Health
7/1/03 → 8/31/09
Project: Research project
Greater New York Autism Research Center of Excellence
Hollander, E., Buxbaum, J. D., Schmeidler, J., Laruelle, M., Buxbaum, J. D., Hollander, E., Rose, S. A., Rose, S. A., Rose, S. A. & Rose, S. A.
National Institute of Mental Health
5/13/03 → 4/30/09
Project: Research project
Divalproex Sodium/Placebo In Child/Adolesent Autism
Hollander, E.
9/30/01 → 8/31/06
Project: Research project

28369 Citations
93 h-Index
329 Article
87 Review article
46 Letter
38 Comment/debate
More

Body dysmorphic disorder: A treatment synthesis and consensus on behalf of the International College of Obsessive-Compulsive Spectrum Disorders and the Obsessive Compulsive and Related Disorders Network of the European College of Neuropsychopharmacology
Castle, D., Beilharz, F., Phillips, K. A., Brakoulias, V., Drummond, L. M., Hollander, E., Ioannidis, K., Pallanti, S., Chamberlain, S. R., Rossell, S. L., Veale, D., Wilhelm, S., Van Ameringen, M., Dell'osso, B., Menchon, J. M. & Fineberg, N. A., Mar 1 2021, In: International Clinical Psychopharmacology. p. 61-75 15 p.
Research output: Contribution to journal › Review article › peer-review
Challenges in assessing change in autistic adults: scale limitations and discrepancies in reporting in clinical trials
Racine, E., Taylor, B. P., Ferretti, C. J., Doernberg, E., Noone, R. H., Nezgovorova, V., Vats, T. & Hollander, E., 2021, (Accepted/In press) In: International Journal of Psychiatry in Clinical Practice.
Research output: Contribution to journal › Comment/debate › peer-review
Gender Differences in Treatment-Seeking Youth with Autism Spectrum Disorder
Cariveau, T., McCracken, C. E., Bradshaw, J., Postorino, V., Shillingsburg, M. A., McDougle, C. J., Aman, M. G., McCracken, J. T., Tierney, E., Johnson, C., Lecavalier, L., Smith, T., Swiezy, N. B., King, B. H., Hollander, E., Sikich, L., Vitiello, B. & Scahill, L., Mar 2021, In: Journal of Child and Family Studies. 30, 3, p. 784-792 9 p.
Research output: Contribution to journal › Article › peer-review
Intranasal oxytocin versus placebo for hyperphagia and repetitive behaviors in children with Prader-Willi Syndrome: A randomized controlled pilot trial
Hollander, E., Levine, K. G., Ferretti, C. J., Freeman, K., Doernberg, E., Desilva, N. & Taylor, B. P., May 2021, In: Journal of Psychiatric Research. 137, p. 643-651 9 p.
Research output: Contribution to journal › Article › peer-review
1 Scopus citations
Potential of cannabinoids as treatments for autism spectrum disorders
Nezgovorova, V., Ferretti, C. J., Taylor, B. P., Shanahan, E., Uzunova, G., Hong, K., Devinsky, O. & Hollander, E., May 2021, In: Journal of Psychiatric Research. 137, p. 194-201 8 p.
Research output: Contribution to journal › Review article › peer-review